These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8697930)

  • 1. [A prospective study of plasma exchange in the treatment of diffuse scleroderma].
    Ding C; Zhang X
    Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):616-9. PubMed ID: 8697930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial.
    Rook AH; Freundlich B; Jegasothy BV; Perez MI; Barr WG; Jimenez SA; Rietschel RL; Wintroub B; Kahaleh MB; Varga J
    Arch Dermatol; 1992 Mar; 128(3):337-46. PubMed ID: 1550365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
    Clements PJ; Furst DE; Wong WK; Mayes M; White B; Wigley F; Weisman MH; Barr W; Moreland LW; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold JR
    Arthritis Rheum; 1999 Jun; 42(6):1194-203. PubMed ID: 10366112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
    Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of systemic scleroderma].
    Priollet P; Baudot N; Fiessinger JN; Vayssairat M; Housset E
    Ann Dermatol Venereol; 1984; 111(6-7):595-607. PubMed ID: 6388467
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of myasthenia gravis caused by D-penicillamine therapy].
    Susa S; Akiba J; Kurimura M; Kurita K; Daimon M; Manaka H; Yamatani K; Kato T
    Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2513-5. PubMed ID: 9922674
    [No Abstract]   [Full Text] [Related]  

  • 7. D-penicillamine in systemic sclerosis? Yes!
    Medsger TA; Lucas M; Wildy KS; Baker C
    Scand J Rheumatol; 2001; 30(4):192-4. PubMed ID: 11578011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term therapy with plasma exchange in systemic sclerosis: effects on laboratory markers reflecting disease activity.
    Cozzi F; Marson P; Rosada M; De Silvestro G; Bullo A; Punzi L; Todesco S
    Transfus Apher Sci; 2001 Aug; 25(1):25-31. PubMed ID: 11791759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with D-penicillamine [see comment].
    Jimenez SA; Sigal SH
    J Rheumatol; 1991 Oct; 18(10):1496-503. PubMed ID: 1765974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects.
    Shapiro LS; Prince RK; Buckingham RB; Rodnan GP
    J Rheumatol; 1983 Apr; 10(2):316-8. PubMed ID: 6864687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [D-penicillamine: an outdated cure for systemic scleroderma?].
    Marie I; Lévesque H; Courtois H
    Rev Med Interne; 1999 Dec; 20(12):1077-81. PubMed ID: 10635068
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of systemic scleroderma using plasma exchange. A study of 19 cases].
    Schmidt C; Schooneman F; Siebert P; Weber M; Dureux JB; Streiff F; Schmitt J
    Ann Med Interne (Paris); 1988; 139 Suppl 1():20-2. PubMed ID: 3247984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The health assessment questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse scleroderma.
    Sultan N; Pope JE; Clements PJ;
    Rheumatology (Oxford); 2004 Apr; 43(4):472-8. PubMed ID: 14679295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive systemic sclerosis and penicillamine.
    Rodnan GP
    J Rheumatol Suppl; 1981; 7():116-20. PubMed ID: 6939873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A patient with systemic scleroderma showing improvement during long-term hemodialysis after renal crisis].
    Fuse Y; Muramatsu M; Sugiyama S; Maeda K
    Ryumachi; 1997 Aug; 37(4):574-80. PubMed ID: 9311284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of D-penicillamine on pulmonary fibrosis in patients with systemic sclerosis.
    Jinnin M; Ihn H; Asano Y; Yamane K; Yazawa N; Tamaki K
    Ann Rheum Dis; 2003 Oct; 62(10):1019-20. PubMed ID: 12972489
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosis and treatment of scleroderma.
    Adnan ZA
    Acta Med Indones; 2008 Apr; 40(2):109-12. PubMed ID: 18560030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of generalized scleroderma with inhibitors of connective tissue formation.
    Asboe-Hansen G
    Acta Derm Venereol; 1975; 55(6):461-5. PubMed ID: 55038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current treatment of scleroderma.
    Oliver GF; Winkelmann RK
    Drugs; 1989 Jan; 37(1):87-96. PubMed ID: 2651089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro inhibition of hematopoiesis in a patient with systemic sclerosis treated with D-penicillamine.
    Katayama Y; Kohriyama K; Matsui T
    J Rheumatol; 1999 Nov; 26(11):2493-5. PubMed ID: 10555917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.